Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-17

Clinical Trial Update: A Study of HRS-9057 in Patients With Heart Failure and Volume Overload [Phase 1]

View source ↗

Summary

Phase 1 study of HRS-9057 in patients with heart failure and volume overload has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-9057

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Heart Failure With Volume Overload | Phase 1 | Status: COMPLETED